Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jan 21;19(3):2041–2050. doi: 10.3892/mmr.2019.9881

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Wang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 5. — Survival curve analysis of hub DEGs for the overall survival in patients with high-risk Wilms tumor. In total, seven hub DEGs (CDK1, OIP5, NUF2, CDCA8, EGF, ENDRA and NGFR) are presented (P<0.05). DEGs, differentially expressed genes; CDK1, cyclin dependent kinase 1; OIP5, opa-interacting protein 5; NUF2, NUF2, NDC80 kinetochore complex component; CDCA8, cell division cycle associated 8; EGF, epidermal growth factor; ENDRA, endothelin receptor type A; NGFR, nerve growth factor receptor.

Figure 5. — Survival curve analysis of hub DEGs for the overall survival in patients with high-risk Wilms tumor. In total, seven hub DEGs (CDK1, OIP5, NUF2, CDCA8, EGF, ENDRA and NGFR) are presented (P<0.05). DEGs, differentially expressed genes; CDK1, cyclin dependent kinase 1; OIP5, opa-interacting protein 5; NUF2, NUF2, NDC80 kinetochore complex component; CDCA8, cell division cycle associated 8; EGF, epidermal growth factor; ENDRA, endothelin receptor type A; NGFR, nerve growth factor receptor.